Home » Topics » BioWorld Science

BioWorld Science
RSS

Aurigene Discovery Technologies describes PRMT5 inhibitors

Oct. 11, 2019

Takeda synthesizes new hSTING agonists

Oct. 11, 2019

Yuhan identifies AOC3 inhibitors

Oct. 11, 2019

SiteOne Therapeutics wins grant to support development of lead candidate for postoperative pain

Oct. 11, 2019

Dual voltage-gated calcium channel and mu-opioid receptor ligands revealed in Esteve patent

Oct. 11, 2019

Chinese researchers patent IDO1 inhibitors

Oct. 11, 2019

N1,N12-Diacetylspermine: a potential urinary biomarker to monitor tuberculosis treatment

Oct. 11, 2019

Heterozygous mouse model of VWD associated with dominant-negative mutations

Oct. 11, 2019

SCR-2682 demonstrates promising activity in rodent MES-induced seizure models

Oct. 11, 2019

Discovery and characterization of second-generation HIF-2alpha inhibitor PT-2977

Oct. 11, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...